Post-Market Clinical Evaluation of the Zephyr Valve 5.5-LP EBV
Condition: Pulmonary Emphysema Intervention: Device: The Pulmonx Zephyr Endobronchial Valve (EBV) 5.5- LP Sponsor: Pulmonx Corporation Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials